591 related articles for article (PubMed ID: 33729906)
1. Folic acid-hydrophilic polymer coated mesoporous silica nanoparticles target doxorubicin delivery.
Al-Nadaf AH; Dahabiyeh LA; Jawarneh S; Bardaweel S; Mahmoud NN
Pharm Dev Technol; 2021 Jun; 26(5):582-591. PubMed ID: 33729906
[TBL] [Abstract][Full Text] [Related]
2. The properties of mesoporous silica nanoparticles functionalized with different PEG-chain length via the disulfide bond linker and drug release in glutathione medium.
Xie Z; Gong H; Liu M; Zhu H; Sun H
J Biomater Sci Polym Ed; 2016; 27(1):55-68. PubMed ID: 26540096
[TBL] [Abstract][Full Text] [Related]
3. Amphiphilic hyperbranched polyester coated rod mesoporous silica nanoparticles for pH-responsive doxorubicin delivery.
Bafkary R; Ahmadi S; Fayazi F; Karimi M; Fatahi Y; Ebrahimi SM; Atyabi F; Dinarvand R
Daru; 2020 Jun; 28(1):171-180. PubMed ID: 32006342
[TBL] [Abstract][Full Text] [Related]
4. Sterically Stabilised Polymeric Mesoporous Silica Nanoparticles Improve Doxorubicin Efficiency: Tailored Cancer Therapy.
Moodley T; Singh M
Molecules; 2020 Feb; 25(3):. PubMed ID: 32046364
[TBL] [Abstract][Full Text] [Related]
5. Folic acid-conjugated polyethylene glycol-coated magnetic nanoparticles for doxorubicin delivery in cancer chemotherapy: Preparation, characterization and cytotoxicity on HeLa cell line.
Erdem M; Yalcin S; Gunduz U
Hum Exp Toxicol; 2017 Aug; 36(8):833-845. PubMed ID: 27758842
[TBL] [Abstract][Full Text] [Related]
6. Thermo- and pH-responsive targeted lipid-coated mesoporous nano silica platform for dual delivery of paclitaxel and gemcitabine to overcome HER2-positive breast cancer.
Nasri N; Saharkhiz S; Dini G; Yousefnia S
Int J Pharm; 2023 Dec; 648():123606. PubMed ID: 37972671
[TBL] [Abstract][Full Text] [Related]
7. A surface-grafted ligand functionalization strategy for coordinate binding of doxorubicin at surface of PEGylated mesoporous silica nanoparticles: Toward pH-responsive drug delivery.
Zhang Q; Zhao H; Li D; Liu L; Du S
Colloids Surf B Biointerfaces; 2017 Jan; 149():138-145. PubMed ID: 27750088
[TBL] [Abstract][Full Text] [Related]
8. Multifunctional DNA-gold nanoparticles for targeted doxorubicin delivery.
Alexander CM; Hamner KL; Maye MM; Dabrowiak JC
Bioconjug Chem; 2014 Jul; 25(7):1261-71. PubMed ID: 24911830
[TBL] [Abstract][Full Text] [Related]
9. Folic acid conjugated cross-linked acrylic polymer (FA-CLAP) hydrogel for site specific delivery of hydrophobic drugs to cancer cells.
Pillai JJ; Thulasidasan AK; Anto RJ; Chithralekha DN; Narayanan A; Kumar GS
J Nanobiotechnology; 2014 Jul; 12():25. PubMed ID: 25026938
[TBL] [Abstract][Full Text] [Related]
10. pH-Sensitive Delivery Vehicle Based on Folic Acid-Conjugated Polydopamine-Modified Mesoporous Silica Nanoparticles for Targeted Cancer Therapy.
Cheng W; Nie J; Xu L; Liang C; Peng Y; Liu G; Wang T; Mei L; Huang L; Zeng X
ACS Appl Mater Interfaces; 2017 Jun; 9(22):18462-18473. PubMed ID: 28497681
[TBL] [Abstract][Full Text] [Related]
11. Polyaspartic acid-anchored mesoporous silica nanoparticles for pH-responsive doxorubicin release.
Hakeem A; Zahid F; Zhan G; Yi P; Yang H; Gan L; Yang X
Int J Nanomedicine; 2018; 13():1029-1040. PubMed ID: 29497295
[TBL] [Abstract][Full Text] [Related]
12. Pegylated magnetic mesoporous silica nanoparticles decorated with AS1411 Aptamer as a targeting delivery system for cytotoxic agents.
Sakhtianchi R; Darvishi B; Mirzaie Z; Dorkoosh F; Shanehsazzadeh S; Dinarvand R
Pharm Dev Technol; 2019 Nov; 24(9):1063-1075. PubMed ID: 30654677
[TBL] [Abstract][Full Text] [Related]
13. Thermo-responsive mesoporous silica/lipid bilayer hybrid nanoparticles for doxorubicin on-demand delivery and reduced premature release.
Zhang Q; Chen X; Shi H; Dong G; Zhou M; Wang T; Xin H
Colloids Surf B Biointerfaces; 2017 Dec; 160():527-534. PubMed ID: 29024917
[TBL] [Abstract][Full Text] [Related]
14. Polymer-Brush-Grafted Mesoporous Silica Nanoparticles for Triggered Drug Delivery.
Zhang L; Bei HP; Piao Y; Wang Y; Yang M; Zhao X
Chemphyschem; 2018 Aug; 19(16):1956-1964. PubMed ID: 29575338
[TBL] [Abstract][Full Text] [Related]
15. Polydopamine coated hollow mesoporous silica nanoparticles as pH-sensitive nanocarriers for overcoming multidrug resistance.
Shao M; Chang C; Liu Z; Chen K; Zhou Y; Zheng G; Huang Z; Xu H; Xu P; Lu B
Colloids Surf B Biointerfaces; 2019 Nov; 183():110427. PubMed ID: 31408782
[TBL] [Abstract][Full Text] [Related]
16. PEG-templated mesoporous silica nanoparticles exclusively target cancer cells.
Morelli C; Maris P; Sisci D; Perrotta E; Brunelli E; Perrotta I; Panno ML; Tagarelli A; Versace C; Casula MF; Testa F; Andò S; Nagy JB; Pasqua L
Nanoscale; 2011 Aug; 3(8):3198-207. PubMed ID: 21725561
[TBL] [Abstract][Full Text] [Related]
17. Folate-conjugated β-cyclodextrin from click chemistry strategy and for tumor-targeted drug delivery.
Zhang H; Cai Z; Sun Y; Yu F; Chen Y; Sun B
J Biomed Mater Res A; 2012 Sep; 100(9):2441-9. PubMed ID: 22566147
[TBL] [Abstract][Full Text] [Related]
18. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
Fan J; Fang G; Wang X; Zeng F; Xiang Y; Wu S
Nanotechnology; 2011 Nov; 22(45):455102. PubMed ID: 22019849
[TBL] [Abstract][Full Text] [Related]
19. Multi-functional nanocarriers based on iron oxide nanoparticles conjugated with doxorubicin, poly(ethylene glycol) and folic acid as theranostics for cancer therapy.
Rajkumar S; Prabaharan M
Colloids Surf B Biointerfaces; 2018 Oct; 170():529-537. PubMed ID: 29966906
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxicity of folic acid conjugated hollow silica nanoparticles toward Caco2 and 3T3 cells, with and without encapsulated DOX.
Patel K; Sundara Raj B; Chen Y; Lou X
Colloids Surf B Biointerfaces; 2016 Apr; 140():213-222. PubMed ID: 26764104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
